Stoke Therapeutics, Inc. (STOK) Earnings
|
Expand Research on STOK
| Next EPS Date | 8/10/26 | EPS Growth Rate | -92.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +571.4% | Revenue Growth Rate | -62.4% |
| Average % Move 1-Wk after EPS | +5.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q226 | N/A | -$0.77 | N/A | N/A | $5.19M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.79 | -$0.81 | +$0.02 | $6.23M | $7.07M | N/A |  | | Details | |
| 3/30/26 |
Q425 | N/A | -$0.73 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 3/23/26 |
Q425 | N/A | -$0.73 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 3/17/26 |
Q425 | N/A | -$0.73 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 3/16/26 |
Q425 | N/A | -$0.73 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 3/13/26 |
Q425 | N/A | -$0.73 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | -$0.73 | N/A | N/A | $5.4M | N/A | N/A | N/A |
